SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
To donate by check, phone, or other method, see our More Ways to Give page.
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
Sen. Bernie Sanders (I-Vt.) and Rep. Elijah Cummings (D-Md.) leave a news conference on Capitol Hill in Washington. (Photo: Susan Walsh/AP)
After 44 state attorneys general filed a lawsuit accusing some of America's largest generic drug manufacturers of a sprawling "multi-year conspiracy" to hike prices on life-saving medicines--in some cases by over 1,000 percent--Sen. Bernie Sanders and Rep. Elijah Cummings on Thursday demanded that the Justice Department launch an investigation into the companies' price-fixing scheme and their alleged efforts to obstruct congressional probes.
"It is sick and disgraceful that generic pharmaceutical executives, who should be making medicines affordable for the American people, were instead busy coordinating a cover-up scheme to hide the truth about their price-fixing conspiracy when we asked about their skyrocketing prices," Sanders said, referring to letters he and Cummings sent in 2014 to inquire about soaring drug costs.
"The Department of Justice must hold these bad actors accountable to the fullest extent of the law."
--Sen. Bernie Sanders
The companies' responses to these inquiries, Sanders said Thursday, amounted to "'polite f-u' letters designed to obstruct our investigation" and "were clearly illegal."
"The Department of Justice must hold these bad actors accountable to the fullest extent of the law," Sanders said.
In their letter (pdf) on Thursday, Sanders and Cummings called on the DOJ to "prioritize criminal enforcement of federal anti-trust laws against generic drug manufacturers."
If the allegations made in the lawsuit by state attorneys general are true, Sanders and Cummings wrote, "civil enforcement will not be sufficient to protect consumers or businesses that compete fairly."
Sanders and Cummings also urged the Justice Department to launch a probe into whether companies "coordinated with each other to mislead our offices' investigation in 2014 into suspicious price increases of generic drugs."
"In response to our document and information requests, these companies gave excuses for raising prices--such as the costs of regulatory compliance, drug shortages, and user fees--that were at best, grossly misleading, and at worst, false statements to Congress," Sanders and Cummings wrote. "For these reasons, we request that the Department of Justice open an investigation."
As Common Dreams reported last month, the lawsuit by 44 state attorneys general--which described the pharma giants' scheme as "one of the most egregious and damaging price-fixing conspiracies in the history of the United States"--named 20 generic drug manufacturers, including Pfizer, Mylan, and Novartis.
Connecticut Attorney General William Tong, whose state led the investigation, said in a statement after the lawsuit was filed that the probe uncovered "hard evidence that shows the generic drug industry perpetrated a multi-billion dollar fraud on the American people."
"We have emails, text messages, telephone records, and former company insiders that we believe will prove a multi-year conspiracy to fix prices and divide market share for huge numbers of generic drugs," said Tong.
Dear Common Dreams reader, The U.S. is on a fast track to authoritarianism like nothing I've ever seen. Meanwhile, corporate news outlets are utterly capitulating to Trump, twisting their coverage to avoid drawing his ire while lining up to stuff cash in his pockets. That's why I believe that Common Dreams is doing the best and most consequential reporting that we've ever done. Our small but mighty team is a progressive reporting powerhouse, covering the news every day that the corporate media never will. Our mission has always been simple: To inform. To inspire. And to ignite change for the common good. Now here's the key piece that I want all our readers to understand: None of this would be possible without your financial support. That's not just some fundraising cliche. It's the absolute and literal truth. We don't accept corporate advertising and never will. We don't have a paywall because we don't think people should be blocked from critical news based on their ability to pay. Everything we do is funded by the donations of readers like you. Will you donate now to help power the nonprofit, independent reporting of Common Dreams? Thank you for being a vital member of our community. Together, we can keep independent journalism alive when it’s needed most. - Craig Brown, Co-founder |
After 44 state attorneys general filed a lawsuit accusing some of America's largest generic drug manufacturers of a sprawling "multi-year conspiracy" to hike prices on life-saving medicines--in some cases by over 1,000 percent--Sen. Bernie Sanders and Rep. Elijah Cummings on Thursday demanded that the Justice Department launch an investigation into the companies' price-fixing scheme and their alleged efforts to obstruct congressional probes.
"It is sick and disgraceful that generic pharmaceutical executives, who should be making medicines affordable for the American people, were instead busy coordinating a cover-up scheme to hide the truth about their price-fixing conspiracy when we asked about their skyrocketing prices," Sanders said, referring to letters he and Cummings sent in 2014 to inquire about soaring drug costs.
"The Department of Justice must hold these bad actors accountable to the fullest extent of the law."
--Sen. Bernie Sanders
The companies' responses to these inquiries, Sanders said Thursday, amounted to "'polite f-u' letters designed to obstruct our investigation" and "were clearly illegal."
"The Department of Justice must hold these bad actors accountable to the fullest extent of the law," Sanders said.
In their letter (pdf) on Thursday, Sanders and Cummings called on the DOJ to "prioritize criminal enforcement of federal anti-trust laws against generic drug manufacturers."
If the allegations made in the lawsuit by state attorneys general are true, Sanders and Cummings wrote, "civil enforcement will not be sufficient to protect consumers or businesses that compete fairly."
Sanders and Cummings also urged the Justice Department to launch a probe into whether companies "coordinated with each other to mislead our offices' investigation in 2014 into suspicious price increases of generic drugs."
"In response to our document and information requests, these companies gave excuses for raising prices--such as the costs of regulatory compliance, drug shortages, and user fees--that were at best, grossly misleading, and at worst, false statements to Congress," Sanders and Cummings wrote. "For these reasons, we request that the Department of Justice open an investigation."
As Common Dreams reported last month, the lawsuit by 44 state attorneys general--which described the pharma giants' scheme as "one of the most egregious and damaging price-fixing conspiracies in the history of the United States"--named 20 generic drug manufacturers, including Pfizer, Mylan, and Novartis.
Connecticut Attorney General William Tong, whose state led the investigation, said in a statement after the lawsuit was filed that the probe uncovered "hard evidence that shows the generic drug industry perpetrated a multi-billion dollar fraud on the American people."
"We have emails, text messages, telephone records, and former company insiders that we believe will prove a multi-year conspiracy to fix prices and divide market share for huge numbers of generic drugs," said Tong.
After 44 state attorneys general filed a lawsuit accusing some of America's largest generic drug manufacturers of a sprawling "multi-year conspiracy" to hike prices on life-saving medicines--in some cases by over 1,000 percent--Sen. Bernie Sanders and Rep. Elijah Cummings on Thursday demanded that the Justice Department launch an investigation into the companies' price-fixing scheme and their alleged efforts to obstruct congressional probes.
"It is sick and disgraceful that generic pharmaceutical executives, who should be making medicines affordable for the American people, were instead busy coordinating a cover-up scheme to hide the truth about their price-fixing conspiracy when we asked about their skyrocketing prices," Sanders said, referring to letters he and Cummings sent in 2014 to inquire about soaring drug costs.
"The Department of Justice must hold these bad actors accountable to the fullest extent of the law."
--Sen. Bernie Sanders
The companies' responses to these inquiries, Sanders said Thursday, amounted to "'polite f-u' letters designed to obstruct our investigation" and "were clearly illegal."
"The Department of Justice must hold these bad actors accountable to the fullest extent of the law," Sanders said.
In their letter (pdf) on Thursday, Sanders and Cummings called on the DOJ to "prioritize criminal enforcement of federal anti-trust laws against generic drug manufacturers."
If the allegations made in the lawsuit by state attorneys general are true, Sanders and Cummings wrote, "civil enforcement will not be sufficient to protect consumers or businesses that compete fairly."
Sanders and Cummings also urged the Justice Department to launch a probe into whether companies "coordinated with each other to mislead our offices' investigation in 2014 into suspicious price increases of generic drugs."
"In response to our document and information requests, these companies gave excuses for raising prices--such as the costs of regulatory compliance, drug shortages, and user fees--that were at best, grossly misleading, and at worst, false statements to Congress," Sanders and Cummings wrote. "For these reasons, we request that the Department of Justice open an investigation."
As Common Dreams reported last month, the lawsuit by 44 state attorneys general--which described the pharma giants' scheme as "one of the most egregious and damaging price-fixing conspiracies in the history of the United States"--named 20 generic drug manufacturers, including Pfizer, Mylan, and Novartis.
Connecticut Attorney General William Tong, whose state led the investigation, said in a statement after the lawsuit was filed that the probe uncovered "hard evidence that shows the generic drug industry perpetrated a multi-billion dollar fraud on the American people."
"We have emails, text messages, telephone records, and former company insiders that we believe will prove a multi-year conspiracy to fix prices and divide market share for huge numbers of generic drugs," said Tong.